PNC Financial Services Group Inc. Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

PNC Financial Services Group Inc. grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 203,508 shares of the company’s stock after buying an additional 14,872 shares during the period. PNC Financial Services Group Inc.’s holdings in GE HealthCare Technologies were worth $16,692,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in GEHC. Laurel Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $26,000. Optima Capital LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Montag A & Associates Inc. lifted its holdings in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the last quarter. Maseco LLP acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $29,000. Finally, Eagle Bay Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Piper Sandler decreased their price objective on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. HSBC decreased their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and decreased their price objective for the stock from $75.00 to $69.00 in a report on Thursday. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a report on Wednesday, April 29th. Finally, Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $80.21.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman bought 1,618 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 12th. The shares were bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Peter J. Arduini bought 4,169 shares of GE HealthCare Technologies stock in a transaction on Thursday, April 30th. The shares were acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 11,847 shares of company stock worth $719,555 over the last 90 days. 0.36% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $64.23 on Friday. The firm has a market cap of $29.22 billion, a PE ratio of 15.37, a price-to-earnings-growth ratio of 1.45 and a beta of 0.74. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company’s 50 day moving average is $68.45 and its two-hundred day moving average is $76.24.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.